Research Grant Awardees in 2020

We are pleased to present the 25 recipients of a research grant in 2020. Congratulations!

Joanne Karen Hobbs
University of Victoria, Victoria, Canada


Project: The prevalence and burden of antibiotic tolerance among Staphylococcus aureus clinical isolates associated with persistent infections

Rémi Planes
Institute of Pharmacology & Structural Biology (IPBS), Toulouse, France

Project: Deciphering how ferroptosis drives Pseudomonas exotoxin U-dependent pathology

Ciaran Kelly
Northumbria University, Newcastle, United Kingdom

Project: The use of synthetic small bacterial RNA mimics to tackle antibiotic resistance

Luke Allsopp
Imperial College London, London, United Kingdom

 Competitive dominance of Pseudomonas aeruginosa

Amelieke Johanna Hendrina Cremers
Radboud University Medical Center, Nijmegen, Netherlands

Genomic epistasis of invasive Streptococcus pneumoniae

Pilar Domingo-Calap
Institute for Integrative Systems Biology, University of Valencia, Paterna, Spain

 Isolation and characterisation of novel Klebsiella pneumoniae phages as a tool for phage therapy against resistant strains

Maxime Pichon
Hopitaux de Poitiers, Poitiers, France

Gastric cartography of Helicobacter pylori resistome and virulome in association with therapeutic failure in humans

Angharad Green
University of Liverpool, Liverpool, United Kingdom

 Understanding the differential metabolic requirements of Streptococcus pneumoniae for nasopharyngeal colonisation versus lung and systemic disease

Delaney Burnard
University of Queensland Centre for Clinical Research, Herston, Queensland, Australia

Exploring the epidemiology and variation of the virulence factor BimABM and antimicrobial resistance within Burkholderia pseudomallei in Australia

Mathieu Blot
François Mitterrand University Hospital, Dijon, France

Impact of Sirt-1 on mitochondrial recovery, innate immune response and outcome during pneumonia

Maria Letizia Di Martino
Uppsala University, Uppsala, Sweden

Revealing the Shigella flexneri epithelial invasome in a human enteroid infection model

Bieke Tack
Institute of Tropical Medicine, Antwerpen, Belgium

Towards evidence-based treatment of children with non-typhoidal Salmonella bloodstream infection in sub-Saharan Africa

Paula Jorge
University of Minho Centre of Biological Engineering, Braga, Portugal

Tailored therapy for COPD polymicrobial pneumonia: nano-based multi-drug particles validated in a “quasi-vivo” air-liquid interface 3D model

Michael Beeton
Cardiff Metropolitan University, Cardiff, United Kingdom

 A novel ‘Trojan horse’ approach to delivering antimicrobial peptide nucleic acids to Mycoplasma genitalium

Alejandro Couce
Technical University of Madrid, Madrid, Spain

Understanding the evolvability of drug-resistance enzymes under strong mutational biases

Aneesh Thakur
University of Copenhagen, Copenhagen, Denmark

Designing a self-administrable and thermostable dry powder tuberculosis subunit vaccine for inhalation: Optimizing adjuvant and pulmonary administration

Pedro Tiago Cardoso Curto
Center for Neuroscience and Cell Biology - University of Coimbra, Cantanhede, Portugal

Deciphering the Rickettsia toolbox to hijack the host

Lonneke Alette van Vught
Academic Medical Center Amsterdam, Amsterdam, Netherlands

 PREMISE: Precision medicine in sepsis

Marte Singsås Dragset
Germans Trias i Pujol Research Institute, Barcelona, Spain

Genome-wide identification of mycobacterial host pathway-specific virulence genes using Drosophila melanogaster

Nadine Bayer
Medical University of Vienna, Vienna, Austria

Mapping microbiome dynamics for early risk stratification of GVHD development after allogeneic hematopoietic stem cell transplantation

Hugo Oliveira
University of Minho, Braga, Portugal

Viral-Based Bioconjugation Platform (ViBBiP) for vaccines development against bacterial pathogens

Laura Judith Marcos Zambrano
IMDEA Food, Madrid, Spain

Profiling host-microbiome interactions in non-responding Celiac Disease symptoms persistence

Aurélie Crabbé
Ghent University, Ghent, Belgium

Exploring the potential of personalized metabolic profiling to evaluate and boost antibiotic activity

Ana P. Tedim
Instituto de Investigación Biomédica de Salamanca, Valladolid, Spain

Improving detection of Blood Stream Infections and antibiotic resistance genes by next generation PCR

Kathy Raven
University of Cambridge, Cambridge, United Kingdom

 Would routine clinical E. faecium sequencing be a useful adjunct to current infection control procedures?

To top